Medical emergency? Call your local emergency number
First aid guides

Menu

Attention deficit hyperactivity disorder (ADHD)

ADHD has a major effect on the prefrontal cortex of the brain Nervous system 5 min read
Not yet medically reviewed. This page has not been checked by a qualified medical reviewer. Use it for general education only and confirm anything important with a healthcare professional. Written by GeoMed Editorial Team. Last updated 27 October 2026.
Treatment depends on the severity of the condition, individual circumstances and local clinical guidelines. This page describes general approaches and does not recommend treatment for any individual.

A neurodevelopmental condition causing ongoing difficulties with attention, hyperactivity and impulsivity that affect daily life.

Overview

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects how the brain manages attention, activity levels and impulses. People with ADHD may find it hard to concentrate, stay organised, sit still or wait their turn, and these difficulties affect school, work, relationships and everyday life.

ADHD usually begins in childhood and often continues into adulthood, although symptoms can change over time. It affects about 5 percent of children and 2 to 3 percent of adults worldwide. It is not caused by poor parenting or lack of effort. With understanding, support and treatment, including behavioural strategies, educational support and medicines, people with ADHD can do very well, and many have strengths such as creativity, energy and the ability to focus intensely on things that interest them.

When to get urgent help

Seek urgent help for thoughts of self-harm or suicide, severe mood changes, or symptoms such as chest pain, fainting or very fast heartbeat while taking ADHD medicine.

Causes and risk factors

  • Genetics: ADHD is highly heritable, with genes accounting for about 70 to 80 percent of risk
  • Premature birth and low birth weight
  • Exposure during pregnancy to smoking, alcohol or some drugs
  • Brain injury
  • Exposure to lead and some other toxins
  • Early severe deprivation or adversity
  • More often diagnosed in boys, while girls are often missed or diagnosed later

How it develops (pathophysiology)

Normal brain control systems

Our ability to focus, plan, control impulses and regulate activity depends on networks in the brain, particularly:

  • The prefrontal cortex, which manages "executive functions" such as attention, working memory, planning and inhibiting impulses
  • The basal ganglia and cerebellum, which help regulate movement and timing
  • Reward circuits, which motivate behaviour

These networks rely on chemical messengers, especially dopamine and noradrenaline, which strengthen useful signals and filter out distractions.

What goes wrong

ADHD involves differences in brain development and function rather than damage:

  1. Delayed brain maturation: imaging studies show the cortex, particularly in frontal regions, matures a few years later on average in children with ADHD.
  2. Network differences: connections within executive control networks are weaker, while the default mode network (active during daydreaming) does not switch off as efficiently during tasks, so the mind wanders.
  3. Dopamine and noradrenaline signalling: differences in how these messengers are released, taken back up and received reduce the brain's ability to sustain attention and control impulses.
  4. Reward processing: people with ADHD often respond more strongly to immediate rewards and find it harder to work for delayed rewards, which can make boring tasks especially difficult.
  5. Timing and emotional regulation: difficulties estimating time and managing frustration are common.

Why the symptoms happen

  • Inattention, such as losing focus, forgetting things and making careless mistakes, reflects weaker sustained attention and working memory.
  • Hyperactivity, such as fidgeting and restlessness, reflects reduced inhibition of movement.
  • Impulsivity, such as interrupting or acting without thinking, reflects difficulty inhibiting responses.
  • Hyperfocus on interesting activities reflects strong engagement of reward systems.
  • Emotional ups and downs reflect difficulties with emotional regulation.

How treatment acts on the mechanism

Stimulant medicines (methylphenidate and amphetamines) increase dopamine and noradrenaline in the gaps between nerve cells by blocking reuptake and increasing release, strengthening attention networks. Non-stimulants such as atomoxetine block noradrenaline reuptake, and guanfacine acts on alpha-2 receptors in the prefrontal cortex. Behavioural therapy, parent training and coaching build skills and create structure that compensates for executive function difficulties.

Types

  • Predominantly inattentive presentation
  • Predominantly hyperactive-impulsive presentation
  • Combined presentation: the most common

Signs and symptoms

Inattention:

  • Difficulty staying focused on tasks or conversations
  • Easily distracted
  • Careless mistakes
  • Forgetfulness and losing things
  • Difficulty organising tasks and managing time
  • Avoiding tasks needing sustained mental effort

Hyperactivity and impulsivity:

  • Fidgeting or restlessness
  • Difficulty sitting still
  • Talking excessively
  • Interrupting others
  • Difficulty waiting
  • Acting without thinking

In adults:

  • Restlessness rather than obvious hyperactivity
  • Disorganisation, procrastination, missed deadlines
  • Difficulty managing money, relationships or work

How it is diagnosed

  • Assessment by a specialist (paediatrician, child psychiatrist, adult psychiatrist or psychologist)
  • Detailed history from the person, family and school
  • Rating scales and questionnaires
  • Symptoms must be present before age 12, in more than one setting, and cause significant impairment
  • Assessment for other conditions, such as autism, learning difficulties, anxiety, depression, sleep problems and hearing or vision problems

Possible complications

  • Difficulties at school and work
  • Low self-esteem
  • Relationship problems
  • Accidents and injuries
  • Anxiety, depression and substance misuse
  • Higher risk of contact with the criminal justice system

Goals of treatment

Treatment aims to reduce symptoms, improve daily functioning at home, school and work, build self-esteem and support wellbeing.

Medicines

  • Stimulants: methylphenidate (first-line in children), lisdexamfetamine (often first-line in adults)
  • Non-stimulants: atomoxetine, guanfacine, clonidine
  • Medicines are started at low doses and adjusted, with monitoring of side effects such as appetite loss, sleep problems, heart rate and blood pressure

Other treatments

  • Parent training and education
  • Behavioural strategies: routines, clear instructions, rewards
  • School support: classroom adjustments, extra time, individual plans
  • Cognitive behavioural therapy for adults and teenagers
  • ADHD coaching
  • Organisational tools: planners, alarms, reminders
  • Physical activity and good sleep habits

Living with it and prevention

ADHD cannot be prevented, but living well with it is helped by:

  • Regular routines
  • Breaking tasks into small steps
  • Regular exercise
  • Good sleep
  • A balanced diet
  • Support groups and peer networks
  • Workplace or school adjustments

Monitoring and follow-up

People on medicine are reviewed regularly to check benefits, side effects, growth (in children), heart rate and blood pressure. Treatment is reviewed at least yearly.

Outlook

ADHD often persists into adulthood, but symptoms may become less obvious. With support and treatment, most people lead successful, fulfilling lives.

Special considerations

  • Girls and women: more likely to have inattentive symptoms and be diagnosed late
  • Adults: may seek diagnosis after their children are diagnosed
  • Pregnancy: medicine decisions should be discussed with a specialist
  • People with heart conditions: need cardiac assessment before stimulants
For students & clinicians (technical detail)

Diagnostic criteria and investigations

DSM-5-TR requires six or more symptoms of inattention and/or hyperactivity-impulsivity (five for those aged 17 and over) for at least six months, present before age 12, in two or more settings, with clear impairment, and not better explained by another condition.

Differential diagnosis

Autism spectrum disorder, learning disorders, anxiety, depression, bipolar disorder, sleep disorders, hearing problems, thyroid disease and the effects of trauma.

Management in detail

Treatment follows national guidance, with medicine offered alongside psychological and educational support. Baseline cardiovascular assessment is performed before starting medicine.

Image credits

References

  1. Health A to Z. NHS (UK). Citation not yet verified
  2. Medicines A to Z. NHS (UK). Citation not yet verified
  3. Medicines information. European Medicines Agency. Citation not yet verified

More Diseases

View all
Gross pathology of idiopathic cardiomyopathy Cardiovascular system

Cardiomyopathy (dilated)

Non-infectious · Chronic

A weakened, enlarged heart muscle that pumps poorly.

1 min read
Reduced blood flow in prefrontal cortex of cannabis users Mental health

Cannabis use disorder

Non-infectious · Chronic

Problematic cannabis use with dependence.

1 min read
A very large hemorrhagic pericardial effusion due to malignancy as seen on ultrasound Cardiovascular system

Cardiac tamponade

Non-infectious · Acute

Fluid around the heart that squeezes it and stops it filling.

1 min read
US Navy -N- G- Hospital Corpsman 3rd Class Flowers administers chest compressions to a simulated cardiac arrest victim Cardiovascular system

Cardiac arrest

Non-infectious · Acute

The heart suddenly stops pumping blood effectively.

1 min read